Oxoid Deutschland GmbH

Oxoid Deutschland GmbH specializes in microbiological culture media and selective agars. These products are designed for identifying and isolating bacteria and mycoplasma in laboratory settings. Examples include enrichment broths like *Mycoplasma/Ureaplasma Enrichment Broth*, selective agars such as *Skirrow Medium* and *MacConkey Agar No. 3*, and diagnostic media like *Thioglycolate Medium* with added hemin and vitamins. The company’s focus is on in vitro diagnostic applications for microbiological testing.

Oxoid Deutschland GmbH is based in Germany, which places its products under the jurisdiction of the European Union’s medical device regulations. Since the company’s devices are classified under EU regulatory frameworks, their compliance aligns with EU-wide standards for medical device safety, performance, and traceability. This includes registration in the EU’s central database, *euDAMED*, ensuring transparency and accountability for its listed devices.

Oxoid Deutschland GmbH’s devices are listed in the *euDAMED* database, which is the European Union’s central registry for medical devices. This registry is crucial because it provides public access to information about devices authorized for use within the EU, including their classification, manufacturer details, and regulatory status. Listing in *euDAMED* ensures compliance with EU requirements and supports transparency for healthcare professionals, regulators, and patients.

Oxoid Deutschland GmbH’s devices fall under *Class A* classification in the EU. This classification applies to low-risk medical devices, such as microbiological culture media and selective agars, which are intended for in vitro diagnostic use. Class A devices typically undergo less stringent regulatory scrutiny than higher-risk classes but still must meet essential safety and performance requirements to ensure their intended use—such as accurate bacterial identification—is achieved without undue risk to users.